| Literature DB >> 28091590 |
Rustem Zairov1,2, Asiya Mustafina1,2, Nataliya Shamsutdinova1,2, Irek Nizameev1,3, Beatriz Moreira4, Svetlana Sudakova1, Sergey Podyachev1, Alfia Fattakhova2, Gulnara Safina4,5, Ingemar Lundstrom6,7, Aidar Gubaidullin1, Alberto Vomiero6.
Abstract
Polyelectrolyte-coated nanoparticles consisting of terbium and gadolinium complexes with calix[4]arene tetra-diketone ligand were first synthesized. The antenna effect of the ligand on Tb(III) green luminescence and the presence of water molecules in the coordination sphere of Gd(III) bring strong luminescent and magnetic performance to the core-shell nanoparticles. The size and the core-shell morphology of the colloids were studied using transmission electron microscopy and dynamic light scattering. The correlation between photophysical and magnetic properties of the nanoparticles and their core composition was highlighted. The core composition was optimized for the longitudinal relaxivity to be greater than that of the commercial magnetic resonance imaging (MRI) contrast agents together with high level of Tb(III)-centered luminescence. The tuning of both magnetic and luminescent output of nanoparticles is obtained via the simple variation of lanthanide chelates concentrations in the initial synthetic solution. The exposure of the pheochromocytoma 12 (PC 12) tumor cells and periphery human blood lymphocytes to nanoparticles results in negligible effect on cell viability, decreased platelet aggregation and bright coloring, indicating the nanoparticles as promising candidates for dual magneto-fluorescent bioimaging.Entities:
Year: 2017 PMID: 28091590 PMCID: PMC5238420 DOI: 10.1038/srep40486
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Structure of 5,11,17,23-tetrakis[(acetylaceton-3-yl)methyl)]-25,26,27,28-tetrahydroxy-calix[4]arene 1 (a) and possible coordination modes of Ln-1 in the alkalized DMF solution (b–f). For more details see ref. 44. TEM image of dried PSS-coated Gd-1 colloids (g), higher resolution TEM image of the same colloids (h), and schematic illustration of PSS-coated Gd-1/Tb-1 nanoparticle and interactions on its core surface with water molecules and UV light (i).
The hydrodynamic diameter, electrokinetic potential (ζ) and polydispersity indices (PDI) of PSS-covered polyelectrolyte nanoparticles as a function of Gd content (χGd = 1, 0.8, 0.6, 0.4, 0.2, 0; χTb = 1 − χGd).
| χGd | Diameter (nm) | PDI | ζ (mV) |
|---|---|---|---|
| 0 | 113.6 ± 1.6 | 0.168 | −29.9 ± 0.1 |
| 0.2 | 106.4 ± 2.0 | 0.153 | −32.6 ± 0.2 |
| 0.4 | 144.4 ± 3.4 | 0.354 | −31.9 ± 0.2 |
| 0.6 | 166.4 ± 2.8 | 0.238 | −33.1 ± 0.2 |
| 0.8 | 123.5 ± 2.2 | 0.168 | −28.3 ± 0.1 |
| 1 | 101.8 ± 1.7 | 0.180 | −29.5 ± 0.1 |
Figure 2X-ray diffraction pattern of the PSS-stabilized Tb-1 colloids.
Two-dimensional X-ray diffraction picture (inset).
Luminescence intensities (I), excited state lifetimes (τ), as well as r1 and r2 of PSS-stabilized Ln-1 (Ln = Tb, Gd) nanoparticles at various χTb and χGd.
| χTb | χGd | I (a.u.) | τ1 (ms) | τ2 (ms) | r1 | r2 |
|---|---|---|---|---|---|---|
| 1 | 0 | 5609000 | 0.271 ± 0.005 | 0.072 ± 0.002 | — | — |
| 0.8 | 0.2 | 4567000 | 0.277 ± 0.004 | 0.066 ± 0.002 | 13,46 | 17,17 |
| 0.6 | 0.4 | 4918000 | 0.284 ± 0.004 | 0.067 ± 0.002 | 10,67 | 12,72 |
| 0.4 | 0.6 | 5204000 | 0.296 ± 0.006 | 0.072 ± 0.003 | 7,62 | 9,02 |
| 0.2 | 0.8 | 2585000 | 0.291 ± 0.005 | 0.066 ± 0.002 | 8,15 | 9,36 |
| 0 | 1 | 3000 | — | 6,83 | 7,86 |
Figure 31/T1 (a) and 1/T2 (b) of PSS-stabilized Ln-1 nanoparticles with various χGd: 1.0 (1), 0.8 (2), 0.6 (3), 0.4 (4), 0.2 (5) versus Gd(III) concentration. Straight lines are linear fitting of the experimental data. Relaxivity values r1 (1-blue) and r2 (2-purple), luminescence intensities (3-red) of PSS-stabilized Ln-1 colloids versus χGd (с). Dashed rectangle reflects the optimal χGd in the colloids core exhibiting the best magnetic and luminescent parameters.
Figure 4(a) Cell viability of periphery human blood lymphocytes without (1) and in the presence of 32 μg/mL of PSS-coated Gd-1 (2), and 66 μg/mL of Tb-1 (3) nanoparticles; PC 12 tumor cells (4) in the presence of 50 μg/mL of PSS-coated Tb-1 colloids (5) and 500 μg/mL of PSS-coated Tb-1 colloids (6). (b) Platelet aggregation in the presence of 10 μM adrenaline (1), 86 μg/mL PSS-coated Gd-1 (3), and 193 μg/mL PSS-coated Tb-1 (4) nanoparticles and without any additives (2) as a per cent of absorptivity changes at 540 nm after 5 min.
Figure 5Images of PC 12 tumor cells: optical (a); confocal in the presence of PSS-coated Tb-1 nanoparticles (b); colored rework of b using GFP emission filter (510–550 nm) (c), λex = 360–370 nm. Scale bar indicates 20 um.